Merck KGaA's lung cancer drugs show promise in early-stage trials
feeds.reuters.comFRANKFURT (Reuters) - Germany's Merck KGaA said two of its experimental oncology drugs showed early signs of promise in certain lung cancer patients,
Congo receives first doses of Ebola vaccine amid outbreak
feeds.reuters.comGENEVA/KINSHASA (Reuters) - The first batch of 4, 000 experimental Ebola vaccines to combat an outbreak suspected of killing 23 people arrived in Cong
Walgreen, Kroger, Albertsons, HEB sue Allergan over dry-eye drug
feeds.reuters.comNEW YORK (Reuters) - Allergan Inc was sued on Wednesday by four large U.S. retailers that accused the drugmaker of antitrust violations for trying to
Roche breast cancer drug treatment time can be halved - study
feeds.reuters.com(Reuters) - Treating early stage breast cancer patients for just six months with Roche's Herceptin works as well as the current 12-month regimen, res
Common cancer treatment works better on men than women: study
globalnews.caA first-line treatment for some cancers seems to have a greater effect on men than women, according to a new study, though researchers aren't sure w
New peanut allergy test is safer and more accurate, researchers say
globalnews.caBritish researchers have devised a new way to test for peanut allergies that could be more effective than what's done now.
FDA chief questions protections on drug rebates, stocks fall
feeds.reuters.com(Reuters) - U.S. Food and Drug Administration chief Scott Gottlieb on Thursday questioned whether rebates that drugmakers provide to health insurers s
Surgeons' skills improve with age
feeds.reuters.com(Reuters Health) - Surgeons' skills may improve with age, and male and female surgeons perform equally well, a recent U.S. study finds.
Sivantos owner EQT forges $8 billion hearing aid deal
feeds.reuters.comCOPENHAGEN/FRANKFURT (Reuters) - Hearing aid makers Widex and Sivantos agreed to merge on Wednesday to form the world's third-largest supplier behind
U.S. state lawsuits against Purdue Pharma over opioid epidemic mount
feeds.reuters.comNEW YORK (Reuters) - Litigation against OxyContin maker Purdue Pharma LP is intensifying as six more U.S. states on Tuesday announced lawsuits, accus